Direct and indirect costs of tuberculosis among immigrant patients in the Netherlands

BMC Public Health

Volumn 9, Issue , 2009, Pages

  Kik, Sandra V ^a,b   Olthof, Sandra Pj ^a   De Vries, Jonie Tn ^a   Menzies, Dick ^c   Kincler, Naomi ^c   Van Loenhout Rooyakkers, Joke ^d   Burdo, Conny ^e   Verver, Suzanne ^a,b  

^a KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c MCGILL UNIVERSITY   (Canada)

^d Municipal Health Service Regio Nijmegen   (Netherlands)

^e Public Health Service of the Rotterdam Region   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; ADULT; AGED; ARTICLE; COST OF ILLNESS; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HEALTH CARE COST; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; IMMIGRANT; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; TUBERCULOSIS; ADOLESCENT; CROSS-SECTIONAL STUDY; ECONOMICS; MIDDLE AGED; MIGRATION;

ADOLESCENT; ADULT; AGED; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; EMIGRATION AND IMMIGRATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; TUBERCULOSIS; YOUNG ADULT;

EID: 69549084994     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-9-283     Document Type: Article

References (22)

1. Financing tuberculosis control: the role of a global financial monitoring system. K Floyd A Pantoja C Dye, Bull World Health Organ 2007 85 5 334 340 10.2471/BLT.06.034942 17639216 (Pubitemid 46718356)
2. Global tuberculosis control: surveillance, planning, financing: WHO report 2008. WHO, Geneva, Switzerland: WHO Press 2008
3. Comparison of cost-effectiveness of tuberculosis screening of close contacts and foreign-born populations. K Dasgupta K Schwartzman R Marchand TN Tennenbaum P Brassard D Menzies, Am J Respir Crit Care Med 2000 162 6 2079 2086 11112118
4. Cost-effectiveness of isoniazid chemoprevention in close contacts. R Diel A Nienhaus T Schaberg, Eur Respir J 2005 26 3 465 473 10.1183/09031936.05. 00047805 16135730 (Pubitemid 41264211)
5. Costs and effectiveness - the impact of economic studies on TB control. K Floyd, Tuberculosis (Edinb) 2003 83 1-3 187 200 10.1016/S1472-9792(02)00077-X 12758211 (Pubitemid 36683571)
6. Impact of DOTS expansion on tuberculosis related outcomes and costs in Haiti. V Jacquet W Morose K Schwartzman O Oxlade G Barr F Grimard D Menzies, BMC Public Health 2006 6 209 10.1186/1471-2458-6-209 16911786 (Pubitemid 44517785)
7. Cost-effectiveness of tuberculosis evaluation and treatment of newly-arrived immigrants. TC Porco B Lewis E Marseille J Grinsdale JM Flood SE Royce, BMC Public Health 2006 6 157 10.1186/1471-2458-6-157 16784541 (Pubitemid 44350143)
8. Determining the cost of tuberculosis case management in a low-incidence state. DJ Rubado D Choi T Becker K Winthrop S Schafer, Int J Tuberc Lung Dis 2008 12 3 301 307 18284836
9. Tuberculosis screening of immigrants to low-prevalence countries. A cost-effectiveness analysis. K Schwartzman D Menzies, Am J Respir Crit Care Med 2000 161 3 Pt 1 780 789 10712322
10. Domestic returns from investment in the control of tuberculosis in other countries. K Schwartzman O Oxlade RG Barr F Grimard I Acosta J Baez E Ferreira RE Melgen W Morose AC Salgado, N Engl J Med 2005 353 10 1008 1020 10.1056/NEJMsa043194 16148286 (Pubitemid 41262335)
11. Cost of tuberculosis diagnosis and treatment from the patient perspective in Lusaka, Zambia. A Aspler D Menzies O Oxlade J Banda L Mwenge P Godfrey-Faussett H Ayles, Int J Tuberc Lung Dis 2008 12 8 928 935 18647453
12. Expenditure and loss of income incurred by tuberculosis patients before reaching effective treatment in Bangladesh. RA Croft RP Croft, Int J Tuberc Lung Dis 1998 2 3 252 254 9526199
13. Economic impact of tuberculosis at the household level. P Kamolratanakul H Sawert S Kongsin S Lertmaharit J Sriwongsa S Na-Songkhla S Wangmane S Jittimanee V Payanandana, Int J Tuberc Lung Dis 1999 3 7 596 602 10423222
14. Socio-economic impact of tuberculosis on patients and family in India. R Rajeswari R Balasubramanian M Muniyandi S Geetharamani X Thresa P Venkatesan, Int J Tuberc Lung Dis 1999 3 10 869 877 10524583
15. The economic burden of illness for households in developing countries: a review of studies focusing on malaria, tuberculosis, and human immunodeficiency virus/acquired immunodeficiency syndrome. S Russell, Am J Trop Med Hyg 2004 71 2 Suppl 147 155 15331831
16. Costs of tuberculosis for households and health care providers in Dar es Salaam, Tanzania. K Wyss P Kilima N Lorenz, Trop Med Int Health 2001 6 1 60 68 10.1046/j.1365-3156.2001.00677.x 11251897 (Pubitemid 32221301)
17. Tuberculosis among foreign-born persons in the United States. KP Cain SR Benoit CA Winston WR Mac Kenzie, Jama 2008 300 4 405 412 10.1001/jama.300.4.405 18647983 (Pubitemid 352040252)
18. What is tuberculosis surveillance in the European Union telling us? D Falzon F Ait-Belghiti, Clin Infect Dis 2007 44 10 1261 1267 10.1086/514343 17443460 (Pubitemid 46717285)
19. Methods for the economic evaluation of health care programmes. MF Drummond MJ Sculpher GW Torrance BJ O'Brien GL Stoddart, New York: Oxford University Press 3 2005
20. CBS, Statistics Netherlands 2005 http://statline.cbs.nl/StatWeb/ publication/?DM=SLNL&PA=70843ned&D1=a&D2=0&D3=0&D4= a&HDR=G1,G2,G3&STB=T&VW=T
21. Reduction of catastrophic health care expenditures by a community-based health insurance scheme in Gujarat, India: current experiences and challenges. MK Ranson, Bull World Health Organ 2002 80 8 613 621 12219151
22. Epidemiologisch onderzoek, opzet en interpretatie. LM Bouter MCJM van Dongen, Houten, Netherlands: Bohn Stafleu van Loghum BV 3 1995